一项质量改进研究:优化人工耳蜗植入儿童的肺炎球菌疫苗接种率
该质量改进研究分析了某三级儿科医院12年间200例人工耳蜗植入儿童的肺炎球菌免疫状况及侵袭性肺炎球菌疾病发生率,并评估电子提醒与护士主导免疫门诊对接种率的影响。基线时88%儿童未按额外推荐完成肺炎球菌疫苗接种,干预后接种率从12%(19/153)升至49%(75/153,p<0.0001),护士主导门诊中42/42(100%)儿童完成Prevenar13接种、34/42(81%)完成Pneumovax23接种。
要点
- 人工耳蜗植入儿童中88%未按指南完成额外推荐的肺炎球菌疫苗接种。
- 电子提醒使肺炎球菌疫苗接种率从基线12%(19/153)升至49%(75/153,p<0.0001)。
- 护士主导免疫门诊中42/42(100%)完成Prevenar13、34/42(81%)完成Pneumovax23接种。
核心结论
- 数据支持将这一模式推广至其他被持续认为接种不足的医学高危儿科群体。
研究设计与样本
- 质量改进研究,纳入200例通过某三级儿科医院儿童听力植入项目接受人工耳蜗植入的儿童,服务范围覆盖西澳大利亚州,研究周期12年。
主要发现
- 多数儿童(88%)未按额外推荐的肺炎球菌疫苗接种要求完成接种。
- 12年研究期间,2%的儿童发生与人工耳蜗植入感染相关的侵袭性肺炎球菌疾病。
- 通用和个性化电子免疫提醒使该儿科人工耳蜗植入场景下的肺炎球菌疫苗接种率从基线12%(19/153)升至实施后49%(75/153,p<0.0001)。
- 护士主导的专用免疫门诊价值得到证实:启动该转诊路径后,所有儿童(42/42,100%)完成Prevenar13接种,多数(34/42,81%)完成Pneumovax23接种。
关键数值与推荐
- 国家和国际指南推荐人工耳蜗植入儿童接种额外肺炎球菌疫苗。
临床怎么用
- 作者认为数据支持将这一模式推广至其他被持续认为接种不足的医学高危儿科群体。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Children with cochlear implants are at increased risk of invasive pneumococcal disease, with national and international guidelines recommending additional pneumococcal vaccines for these children. This study aimed to examine the pneumococcal immunization status and rate of invasive pneumococcal disease in children with cochlear implants at a tertiary paediatric hospital over a 12-year period. Additionally, the impacts of vaccination reminders and a dedicated immunization clinic on pneumococcal vaccination rates were assessed. This quality improvement study included 200 children who had received a cochlear implant through the Children's Hearing Implant Program at a tertiary paediatric hospital servicing the state of Western Australia. The majority of children (88%) were not up to date with additionally recommended pneumococcal vaccinations. Over the 12-year study period, 2% of children developed invasive pneumococcal disease associated with cochlear implant infections. Generic and personalized electronic immunization reminders improved pneumococcal vaccine up-take in this paediatric cochlear implant setting from 12% (19/153) at baseline to 49% (75/153, p < 0.0001) post implementation. The value of a nurse-led dedicated immunization clinic was also demonstrated with all children (42/42, 100%) up to date with Prevenar13 and the majority (34/42, 81%) up to date with Pneumovax23 post initiation of this referral pathway. These data support the expansion of this model to other medically-at-risk paediatric groups that have been highlighted consistently to be under-vaccinated.
引用
- Tay S, Bowen AC, Blyth CC, et al. A quality improvement study: Optimizing pneumococcal vaccination rates in children with cochlear implants. Vaccine. 2022. PMID: 35718588. doi:10.1016/j.vaccine.2022.06.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。